6-(环丙烷甲酰胺基)-4-((2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯基)氨基)-N-(甲基-d3)哒嗪-3-甲酰胺
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
产品编号 :
ACOLNF295
Cas No. :
1609392-27-9
包装规格
纯度
目录价
会员专享价
库存
数量
1mg
99%
¥100
询价
5mg
99%
¥120
询价
10mg
99%
¥145
询价
250mg
99%
¥370
询价
1g
99%
¥999
询价
5g
99%
¥2666
询价
10g
99%
¥4000
询价
25g
99%
¥8000
询价
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
1609392-27-9
中文名称
6-(环丙烷甲酰胺基)-4-((2-甲氧基-3-(1-甲基-1H-1,2,4-三唑-3-基)苯基)氨基)-N-(甲基-d3)哒嗪-3-甲酰胺
英文名称
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
别名
Deucravacitinib | NSC825520 | compound 11 [PMID: 31318208} | EN300-22276121 | Deucravacitinib [USAN] | (BMS-986165) | SCHEMBL20520348 | Sotyktu | AT18623 | DEUCRAVACITINIB [JAN] | 6-[(Cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3
标准英文名
6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide
MDL No.
MFCD31715455
分子式
C2 0 H2 2 N8 O3
分子量
425.47
精确分子量
425.20
SMILES
[2H]C([2H])([2H])NC(=O)C1=NN=C(NC(=O)C2CC2)C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC
标准SMILES
[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC1=CC=CC(C2=NN(C)C=N2)=C1OC)NC(=O)C1CC1
用途
Deucravacitinib (BMS-986165) is a first-in-class, oral, selective tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of moderate-to-severe plaque psoriasis; it represents a promising therapeutic option for effective management of psoriasis due to its unique mechanism of action.
InChIKey
BZZKEPGENYLQSC-FIBGUPNXSA-N
SureRoute逆合成路线
1. 1609392-27-9 逆合成路线 1
ACFADS597
1609394-10-6
现货